Health Care & Life Sciences » Biotechnology | 22nd Century Group Inc.

22nd Century Group Inc.

22nd Century Group Inc.
Stock Exchange NYSE
EPS
$0.09
Market Cap
$243.09 M
Shares Outstanding
124.66 M
Public Float
113.33 M
22nd Century Group Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
124.37 M
Public Float
115.25 M

Profile

Address
8560 Main Street
Clarence New York 14221
United States
Employees -
Website http://www.xxiicentury.com
Updated 07/08/2019
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on January 25, 2011 and is headquartered in Clarence, NY.

Financials

View All
Created with Highcharts 5.0.1422nd Century Group Inc.Net Income. Fiscal year is January-December. All values USD Thousands.26 15326 15315 59515 59511 03111 03111 58111 58113 02913 0297 9667 96620132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.1422nd Century Group Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.7 2787 2785295298 5228 52212 28012 28016 60016 60026 42626 42620132014201520162017201805k10k15k20k25k30k

Henry Sicignano
President, Chief Executive Officer & Director
James W. Cornell
Chairman